Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14667472 | 1.00 | CTBP2 (0.52) | CTBP2KDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL10177334 | 1.00 | CTBP2 (0.52) | CTBP2KDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL25620241 | 0.83 | KDM4E (0.50) | CTBP2KDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL11254350 | 0.82 | ALOX5 (0.57) | ALDH1A1SMN1; SMN2L3MBTL1CYP2C19HDAC6 | |
| SCHEMBL13902884 | 0.81 | KDM4E (0.49) | CTBP2KDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL19433078 | 0.81 | KDM4E (0.49) | CTBP2KDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL362289 | 0.79 | CTBP2 (0.55) | CTBP2ALDH1A1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL28007823 | 0.79 | CTBP2 (0.52) | CTBP2ALDH1A1SMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL10889866 | 0.79 | PLAU (0.42) | CTBP2KDM4EALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL8570445 | 0.79 | KDM4E (0.47) | CTBP2KDM4EALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114835660-A | Preparation method of oxime ether | 浙江理工大学 | 2022-08-02 | — | — | CN | claimed |
| CN-110015974-B | Preparation method of cyclododecanone oxime | 万华化学集团股份有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-107488090-B | Efficient catalytic asymmetric preparation method of N-cyclopropyl nitrone compound | 东北师范大学 | 2020-06-02 | — | — | CN | claimed |
| EP-1527165-A4 | A RHODOCOCCUS GENE ENCODING ALDOXIME DEHYDRATASE | DU PONT (US) | 2006-06-07 | — | — | EP | claimed |
| EP-1527165-A2 | A RHODOCOCCUS GENE ENCODING ALDOXIME DEHYDRATASE | E.I. du Pont de Nemours and Company (US) | 2005-05-04 | — | — | EP | claimed |
| WO-2003078581-A2 | A RHODOCOCCUS GENE ENCODING ALDOXIME DEHYDRATASE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-09-25 | — | — | WO | claimed |
| JP-3145448-A | — | — | None | — | — | JP | disclosed |
| US-11871754-B1 | Promoting growth, yield, and salinity tolerance of Achillea fragrantissima | King Faisal University (SA) | 2024-01-16 | — | — | US | disclosed |
| US-20230321010-A1 | Amphetamine Controlled Release, Prodrug, and Abuse-deterrent Dosage Forms | CHEMAPOTHECA, LLC (US) | 2023-10-12 | — | — | US | disclosed |
| US-11717498-B2 | Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage forms | Pharmapotheca A, Inc. (US) | 2023-08-08 | — | — | US | disclosed |
| CN-114835660-A | Preparation method of oxime ether | 浙江理工大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-110015974-B | Preparation method of cyclododecanone oxime | 万华化学集团股份有限公司 | 2022-01-07 | — | — | CN | disclosed |
| US-11123310-B2 | Amphetamine controlled release, prodrug, and abuse-deterrent dosage forms | PHARMAPOTHECA, LLC (US) | 2021-09-21 | — | — | US | disclosed |
| CN-85108668-A | The preparation method of diphenyl ether herbicide | — | 1986-05-10 | — | — | CN | disclosed |
| US-4581365-A | Trichloroacryloyl oxime fungicides | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-04-08 | — | — | US | disclosed |
| EP-0112524-A1 | Trichloroacryloyl oxime derivatives | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1984-07-04 | — | — | EP | disclosed |
| EP-0023560-A1 | Process for preparing O-substituted ketoximes | BASF Aktiengesellschaft (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-4190656-A | VIRICIDES, ANTITUMOR AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1980-02-26 | — | — | US | disclosed |
| US-4176121-A | INSECTICIDES, MITICIDES; CYCLIZATION OF METHYL KETONE OXIME WITH A HALOACETYL CHLORIDE, REACTION WITH A THIOPHOSPHORIC OR THIOPHOSPHO | STAUFFER CHEMICAL COMPANY (US) | 1979-11-27 | — | — | US | disclosed |
| US-4137308-A | 1,3-Oxazole phosphates and phosphonates as insecticides and miticides | STAUFFER CHEMICAL COMPANY (US) | 1979-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11123310-B2 | Amphetamine controlled release, prodrug, and abuse-deterrent dosage forms | SLC6A3, CES2, SLC6A2 | CTBP2 2479/4885KDM4E 808/4885ALDH1A1 682/4885 |
| US-11717498-B2 | Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage forms | SLC6A3, SLC6A2, CES2 | CTBP2 2394/4885KDM4E 882/4885ALDH1A1 687/4885 |
| US-20230321010-A1 | Amphetamine Controlled Release, Prodrug, and Abuse-deterrent Dosage Forms | SLC6A3, CES2, SLC6A2 | CTBP2 2357/4885KDM4E 895/4885ALDH1A1 578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.